Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             59 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acceptance in adolescents with cystic fibrosis: a prospective study Casier, A.
 2010
 9 Supplement 1 p. S97-
1 p.
 artikel
2 A dedicated CF chef improves nutritional state and weight gain for CF inpatients Pandya, S.
 2010
 9 Supplement 1 p. S89-
1 p.
 artikel
3 Altered expression of T-cell immunoglobulin and mucin-domain-containing molecule-1 (TIM-1) and TIM-3 in the cystic fibrosis airway Vega-Carrascal, I.
 2010
 9 Supplement 1 p. S46-
1 p.
 artikel
4 Alveolar inflammation in cystic fibrosis Ulrich, Martina
 2010
 9 Supplement 1 p. 217-227
11 p.
 artikel
5 An audit of hearing assessment in a regional paediatric cystic fibrosis centre Bader, A.A.
 2010
 9 Supplement 1 p. S44-
1 p.
 artikel
6 An ex vivo sputum model to evaluate antibacterial treatments in CF patients chronically colonized with Pseudomonas aeruginosa Glonti, T.
 2010
 9 Supplement 1 p. S39-
1 p.
 artikel
7 A real-life glucose tolerance test in children to screen for CFRD Zwolsman, M.G.
 2010
 9 Supplement 1 p. S93-
1 p.
 artikel
8 Are the psychosocial needs of cystic fibrosis patients being met post-transplant? Miller, C.
 2010
 9 Supplement 1 p. S104-
1 p.
 artikel
9 A retrospective review of pathogens infecting the lungs of adults with cystic fibrosis Ramsay, K.A.
 2010
 9 Supplement 1 p. S25-
1 p.
 artikel
10 A survey of exercise testing and training in UK cystic fibrosis clinics Stevens, D.
 2010
 9 Supplement 1 p. 302-306
5 p.
 artikel
11 Author Index 2010
 9 Supplement 1 p. S123-S132
10 p.
 artikel
12 Birth weight, feeding practices and pancreatic enzyme replacement therapy (PERT) in infants diagnosed with cystic fibrosis by newborn screening – 10 years experience Wolfe, S.P.
 2010
 9 Supplement 1 p. S85-
1 p.
 artikel
13 CF patients' experience of an adult ward following transition – an on-line survey Cunha, A.
 2010
 9 Supplement 1 p. S107-
1 p.
 artikel
14 Commercial garlic preparations inhibit quorum sensing lasB and pqsA gene expression in Pseudomonas aeruginosa clinical strains Hurley, M.
 2010
 9 Supplement 1 p. S21-
1 p.
 artikel
15 Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis Bennett, Antonia V.
 2010
 9 Supplement 1 p. 419-424
6 p.
 artikel
16 Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint Konstan, M.W.
 2010
 9 Supplement 1 p. 332-338
7 p.
 artikel
17 Detection of viruses in pulmonary exacerbations in CF De Schutter, I.
 2010
 9 Supplement 1 p. S51-
1 p.
 artikel
18 Development of medicines for children with CF under the new European paediatric regulation Eichler, I.
 2010
 9 Supplement 1 p. S117-
1 p.
 artikel
19 Does body position during inhalation of a nebulised aerosol influence the pattern of deposition in adults with and without cystic fibrosis (CF)? Dentice, R.L.
 2010
 9 Supplement 1 p. S74-
1 p.
 artikel
20 Editorial Board 2010
 9 Supplement 1 p. 2-
1 p.
 artikel
21 Effect of early physiotherapy intervention in CF babies persists at least till 12 years of age Smolikova, L.
 2010
 9 Supplement 1 p. S75-
1 p.
 artikel
22 Effect of tobramycin on Pseudomonas aeruginosa populations in artificial sputum media Mowat, E.
 2010
 9 Supplement 1 p. S43-
1 p.
 artikel
23 Efficacy and safety of tobramycin and colistin for inhalation in children with cystic fibrosis from Moscow region Nikonova, V.S.
 2010
 9 Supplement 1 p. S54-
1 p.
 artikel
24 End of life care in cystic fibrosis – are we offering a good service? Rashid, R.
 2010
 9 Supplement 1 p. S66-
1 p.
 artikel
25 Exercise and quality of life in patients with cystic fibrosis – a 12-week intervention study Schmidt, A.M.
 2010
 9 Supplement 1 p. S71-
1 p.
 artikel
26 Gastroesophageal reflux disease in cystic fibrosis patients Pop, L.
 2010
 9 Supplement 1 p. S78-
1 p.
 artikel
27 Genomovar prevalence of Burkholderia cepacia complex (BCC) in a cystic fibrosis reference center in Brazil Dentini, P.
 2010
 9 Supplement 1 p. S27-
1 p.
 artikel
28 High dose intermittent ticarcillin–clavulanate administration in pediatric cystic fibrosis patients Zobell, Jeffery T.
 2010
 9 Supplement 1 p. 280-283
4 p.
 artikel
29 Illness perception does not predict treatment concordance in adults with cystic fibrosis Clayton, A.A.
 2010
 9 Supplement 1 p. S101-
1 p.
 artikel
30 Inhibition of lipopolysaccharide signalling by LL-37 and repercussions for LL-37 function in the Pseudomonas-infected cystic fibrosis lung Scott, A.
 2010
 9 Supplement 1 p. S48-
1 p.
 artikel
31 Investigation of Colifin® (1 and 2 million international units colistimethate sodium, CMS) for aerosolisation in the eFlow® rapid and PARI LC SPRINT® nebuliser Brendel, E.
 2010
 9 Supplement 1 p. S42-
1 p.
 artikel
32 Iron status of paediatric cystic fibrosis patients Williams, A.
 2010
 9 Supplement 1 p. S92-
1 p.
 artikel
33 Isolation of Exophiala dermatitidis in cystic fibrosis: is ECA the optimal medium? Boeras, A.
 2010
 9 Supplement 1 p. S35-
1 p.
 artikel
34 Is telemedicine useful in home management of cystic fibrosis patients? Bella, S.
 2010
 9 Supplement 1 p. S61-
1 p.
 artikel
35 Long term outcome of liver transplantation (LT) for patients with cystic fibrosis liver disease (CFLD) van Mourik, I.
 2010
 9 Supplement 1 p. S81-
1 p.
 artikel
36 Lung function, employment and benefits in an adult CF population Nazareth, D.
 2010
 9 Supplement 1 p. S108-
1 p.
 artikel
37 Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection Gilljam, Marita
 2010
 9 Supplement 1 p. 272-276
5 p.
 artikel
38 Modes of interaction between Pseudomonas aeruginosa and obligate anaerobes Worlitzsch, D.
 2010
 9 Supplement 1 p. S31-
1 p.
 artikel
39 Multicentre randomised double blind placebo controlled trial assessing the effect of weekly risedronate on bone mineral density in adults with cystic fibrosis Haworth, C.S.
 2010
 9 Supplement 1 p. S85-
1 p.
 artikel
40 Newborn screening for cystic fibrosis (NBSCF) in region Moravia, Czech Republic Valaskova, I.
 2010
 9 Supplement 1 p. S9-
1 p.
 artikel
41 “Old” patients with CF: report from Brittany (Western France) where CF is frequent Scotet, V.
 2010
 9 Supplement 1 p. S112-
1 p.
 artikel
42 Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis Shead, Elizabeth F.
 2010
 9 Supplement 1 p. 93-98
6 p.
 artikel
43 Particle size determination of a generic nebulized tobramycin Kofman, C.D.
 2010
 9 Supplement 1 p. S62-
1 p.
 artikel
44 Platelet proinflammatory activity in clinically stable patients with CF starts in early childhood Sturm, Alexander
 2010
 9 Supplement 1 p. 179-186
8 p.
 artikel
45 Polymorphisms in GCLC and GST (M1, T1 and P1) genes and their performance in clinical severity of cystic fibrosis (CF) Marson, F.A.L.
 2010
 9 Supplement 1 p. S4-
1 p.
 artikel
46 Post-translational regulation of alginate export by an oxygen sensor in Pseudomonas aeruginosa Schmidt, A.
 2010
 9 Supplement 1 p. S32-
1 p.
 artikel
47 Potential of denufosol as an early intervention in CF lung disease: efficacy in patients with minimal pharmacotherapy in a US phase 3 clinical trial Accurso, F.J.
 2010
 9 Supplement 1 p. S21-
1 p.
 artikel
48 Predictors of the time until the next pulmonary exacerbation in adult CF patients Sequeiros, I.M.
 2010
 9 Supplement 1 p. S58-
1 p.
 artikel
49 Pre-emptive transjugular intrahepatic porto-systemic shunt (TIPSS) for portal hypertension from cystic fibrosis liver disease: 1 year evaluation Robberecht, E.
 2010
 9 Supplement 1 p. S81-
1 p.
 artikel
50 Re-emergence of luciferase expression in lung following a single nasal instillation of a lentiviral vector in normal and cystic fibrosis mice Cmielewski, P.
 2010
 9 Supplement 1 p. S17-
1 p.
 artikel
51 Renal impairment in children with cystic fibrosis Andrieux, Annick
 2010
 9 Supplement 1 p. 263-268
6 p.
 artikel
52 Rescue of the protein folding defect in cystic fibrosis in vitro by the investigational small molecule, VX-809 Van Goor, F.
 2010
 9 Supplement 1 p. S14-
1 p.
 artikel
53 Respiratory pathogens in patients with cystic fibrosis. Reviewing the past 15 years De los Rios Perez, A.M.
 2010
 9 Supplement 1 p. S54-
1 p.
 artikel
54 [R74W;R1070W;D1270N]: A new complex allele responsible for cystic fibrosis de Prada Merino, Ana
 2010
 9 Supplement 1 p. 447-449
3 p.
 artikel
55 Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis Olesen, Hanne Vebert
 2010
 9 Supplement 1 p. 257-262
6 p.
 artikel
56 Serum tobramycin levels following delivery of tobramycin (Tobi®) via eFlow® advanced nebuliser in children with cystic fibrosis Guy, E.L.
 2010
 9 Supplement 1 p. 292-295
4 p.
 artikel
57 Simultaneous detection of common cystic fibrosis mutations by reverse-hybridization teststrips Puehringer, H.
 2010
 9 Supplement 1 p. S13-
1 p.
 artikel
58 Tobacco smoke exposure and effectiveness of a smoking cessation program in cystic fibrosis patients and their relatives Pastor-Vivero, M.D.
 2010
 9 Supplement 1 p. S117-
1 p.
 artikel
59 Year-to-year changes in lung function in individuals with cystic fibrosis Liou, Theodore G.
 2010
 9 Supplement 1 p. 250-256
7 p.
 artikel
                             59 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland